Wara Samar
14th October 2024
2024 MedTech Innovator Grand Prize Finalists Gear Up for The MedTech Conference
The race in groundbreaking medtech innovation is heating up. MedTech Innovator (MTI), the world’s largest accelerator for medical technology startups, has announced five finalists for its 2024 Grand Prize competition. These early-stage companies will compete for the top prize at The MedTech Conference, powered by AdvaMed, from October 15-17 in Toronto. This competition is the culmination of MTI’s accelerator program, which supports promising startups working on advancements in the medtech industry.
MTI’s CEO Paul Grand said, “After four months of mentoring, the senior leadership at our strategic partners championed 29 of their top mentees for the coveted finalist slots so you know these startups truly embody the potential to dramatically improve healthcare delivery and outcomes for millions of patients worldwide.”
Grand Prize Finals: A Key Event at The MedTech Conference
On October 16, at 4:00 pm ET, the five finalists will present their innovative solutions in the Keynote Theater. Selection to the finals already secured each company $25,000 and they will now vie for the $350,000 non-dilutive Grand Prize. The finalists will pitch their companies and solutions to a panel of industry experts from leading medtech companies, and the conference audience will vote in real-time to decide the winner.
The MedTech World team will be attending the conference, with Dr. Dylan Attard, CEO, Yulia Yurevich, Head of Client Relations and Partnerships, and Diane Bouis, Director US, there to support their colleagues and friends in the medtech industry.
Dr. Dylan Attard noted, “We’re excited to attend The MedTech Conference this year and witness firsthand the innovations from these remarkable finalists. The MedTech Innovator competition not only shines a spotlight on emerging technologies but also fosters the kind of collaboration that drives meaningful progress in healthcare. I’m eager to see how these solutions can inspire the next wave of advancements and impact patient care globally.”
The Finalists: Practical Solutions to Pressing Medical Challenges
The five finalists represent a diverse range of technologies aimed at improving patient care:
BrainSpace: A wearable continuous ICP monitor and automated CSF drain designed to ease the burden on ICU resources while generating AI-ready data. Caitlin Morse, CEO of BrainSpace, shared, “BrainSpace has benefitted from the generosity of many experts in the MTI ecosystem. It is our privilege to present on the future of neuro innovation in the Grand Finals at the AdvaMed conference.”
Flow Medical: A next-generation PE Thrombolysis catheter that combines drug infusion with real-time hemodynamic monitoring to provide personalized treatment for patients. Jennifer Fried, Co-Founder and CEO, commented, “This is my second time going through MTI as a founder/CEO, and going through the program has been even better this time around! Our team at Flow Medical is honored to be a finalist on stage in Toronto and feel proud to be among this excellent peer group of the entire 2024 MTI cohort.”
NeuroBionics: A minimally invasive device for endovascular deep brain stimulation, aimed at improving outcomes for stroke rehabilitation patients. MJ Antonini, PhD, Co-Founder and CEO of NeuroBionics, said, “We are very excited to be selected as a MedTech Innovator Early-Stage Finalist, and eager to showcase NeuroBionics’ mission to make life-changing neuromodulation therapy more accessible to all.”
Samay: Acoustic resonance patches for the diagnosis and management of COPD, a condition that affects millions worldwide. Maria Artunduaga, Founder & CEO, emphasized the importance of addressing this issue: “Worldwide, COPD affects 1 of every 10 adults and kills 6 people every minute. We’re excited to use this opportunity to bring attention to a disease that remains overlooked and underfunded.”
Juniper Biomedical: An implantable neuromodulation platform designed to enhance treatment options for urinary incontinence and other pelvic health conditions.
Takeaway
As the 2024 MedTech Innovator Grand Prize finalists prepare to present in Toronto, their pioneering solutions highlight the potential to address critical healthcare challenges. With real-time audience participation and feedback from industry experts, the Grand Prize finals will be a key moment in showcasing emerging technologies that could transform patient care and improve outcomes worldwide. MedTech World eagerly anticipates seeing the impact these startups will make on the global healthcare landscape.
Get Ready for MedTech Malta 2024!
Join a distinguished lineup of medtech and healthtech leaders this November at MedTech Malta 2024. Take advantage of the opportunity to hear from global experts and participate in thought-provoking discussions on the future of healthcare innovation. Reserve your spot now for November 6-8 at the iconic Mediterranean Conference Centre in Valletta, Malta.
